Loading...
Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.
Vitale, Domenico Colarossi, Lorenzo Russo, Gianluca Scimone, Claudia Cozzolino, Domenico De Luca, Caterina Prjibelski, Andrey D Mikheenko, Alla Colarossi, Cristina Delli Muti, Francesco
Vitale, Domenico
Colarossi, Lorenzo
Russo, Gianluca
Scimone, Claudia
Cozzolino, Domenico
De Luca, Caterina
Prjibelski, Andrey D
Mikheenko, Alla
Colarossi, Cristina
Delli Muti, Francesco
Files
Loading...
document.pdf
Adobe PDF, 690.09 KB
Supervisor
Department
Computational Biology
Embargo End Date
Type
Journal article
Date
License
http://creativecommons.org/licenses/by/4.0/
Language
English
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Next generation sequencing (NGS) impacted on clinical algorithm of solid tumor patients. A heterogeneous series of NGS platforms have been implemented in clinical practice but challenging handling procedures, high technical costs, and scant affordability on sequencing diagnostic routine specimens can leave behind some patients who could benefit from target drugs. Here, we sought to evaluate technical feasibility of Oxford Nanopore Technologies (ONT) sequencing accurate identification of tumor-associated molecular alterations, in a pilot series of real-world samples.
Methods: We developed a technical workflow adapting the SiRe® NGS panel, originally designed for Ion semiconductor sequencing, on MinION platform (Oxford nanopore technologies), a portable, cost effective long read sequencer. The SiRe® panel enables detection of ٥٦٨ clinically actionable somatic mutations across six key genes (<i>EGFR, KRAS, NRAS, BRAF, cKIT, PDGFRα</i>) relevant to targeted therapies in several solid tumors. We implemented a multiplexed assay using pooled and barcoded samples, processed on a single MinION flow cell. Performance was benchmarked from a pilot series of nine FFPE samples against Ion Torrent sequencing data. A single liquid biopsy sample was also analyzed testing accuracy of MinION technology.
Results: The adapted ONT workflow demonstrated high concordance ratei in detecting clinically relevant molecular alterations on short-read fragments, achieving comparable accuracy with standardized second generation NGS platforms on tissue and liquid biopsy samples.
Conclusions: This proof of concept aimed to integrate ONT sequencing into molecular oncology workflows, providing practical, low-cost, and scalable alternative to conventional NGS platforms. The results support the potential of ONT technology to democratize access to precision oncology, particularly in laboratories with limited resources.
Citation
D. Vitale, L. Colarossi, G. Russo, C. Scimone, D. Cozzolino, C. De Luca , et al., "Technical feasibility of a long read, fourth generation sequencing platform in diagnostic profiling of clinical routine samples: a proof-of-concept study.," Pathologica, vol. 118, no. 2, pp. 118-125, 2026, https://doi.org/10.32074/1591-951x-1936.
Source
Pathologica
Conference
Keywords
31 Biological Sciences, 3102 Bioinformatics and Computational Biology, 32 Biomedical and Clinical Sciences, 3202 Clinical Sciences, 3211 Oncology and Carcinogenesis, Biomarkers, Tumor, DNA Mutational Analysis, Feasibility Studies, High-Throughput Nucleotide Sequencing, Humans, Mutation, Neoplasms, Pilot Projects, Proof of Concept Study, 3 Good Health and Well Being
Subjects
Source
Publisher
Siapec Servizi Srl